Arcus Biosciences, Inc.
NYSE:RCUS
16.46 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 117 | 112 | 382.882 | 77.517 | 15 | 8.353 | 1.413 | 0 |
| Kosten van de omzet
| 16 | 14 | 7.057 | 159 | 78.481 | 49.646 | 2.612 | 1.314 |
| Brutowinst
| 101 | 98 | 375.825 | -81.483 | -63.481 | -41.293 | -1.199 | -1.314 |
| Brutowinstmarge
| 0.863 | 0.875 | 0.982 | -1.051 | -4.232 | -4.943 | -0.849 | 0 |
| Onderzoek- en ontwikkelingskosten
| 340 | 288 | 256.348 | 159.348 | 78.481 | 49.646 | 47.218 | 14.247 |
| Algemene en administratieve kosten
| 117 | 104 | 72.286 | 42.404 | 25.228 | 13.566 | 7.636 | 3.935 |
| Verkoop- en marketingkosten
| 17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 117 | 104 | 72.286 | 42.404 | 25.228 | 13.566 | 7.636 | 3.935 |
| Overige kosten
| -340 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 457 | 392 | 328.634 | 201.752 | 103.709 | 63.212 | 54.854 | 18.182 |
| Bedrijfsresultaat
| -340 | -280 | 54.248 | -124.235 | -88.709 | -54.859 | -53.441 | -18.182 |
| Bedrijfsresultaat ratio
| -2.906 | -2.5 | 0.142 | -1.603 | -5.914 | -6.568 | -37.821 | 0 |
| Totaal overige inkomsten en kosten netto
| 39 | 14 | 0.397 | 1.377 | 3.999 | 0.343 | 0.359 | 0.212 |
| Inkomen voor belasting
| -301 | -266 | 54.645 | -122.858 | -84.71 | -49.594 | -53.082 | -17.97 |
| Inkomen voor belasting ratio
| -2.573 | -2.375 | 0.143 | -1.585 | -5.647 | -5.937 | -37.567 | 0 |
| Belastingkosten
| 6 | 1 | 1.815 | -6.181 | -8.779 | 5.265 | 0 | 0 |
| Nettowinst
| -307 | -267 | 53 | -116.677 | -75.931 | -49.594 | -53.082 | -17.97 |
| Nettowinstmarge
| -2.624 | -2.384 | 0.138 | -1.505 | -5.062 | -5.937 | -37.567 | 0 |
| WPA (Winst Per Aandeel)
| -4.15 | -3.71 | 0.76 | -2.13 | -1.73 | -1.43 | -1.25 | -0.73 |
| Verwaterde WPA
| -4.15 | -3.71 | 0.71 | -2.13 | -1.73 | -1.43 | -1.25 | -0.73 |
| EBITDA
| -291 | -264 | 54.905 | -124.848 | -88.709 | -56.088 | -50.829 | -16.868 |
| EBITDA ratio
| -2.487 | -2.357 | 0.143 | -1.611 | -5.914 | -6.715 | -35.972 | 0 |